MedPath

Bayer Oy

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:2
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:9
SFDA:5
PHILIPPINES:2

Drug Approvals

Levonorgestrel Intrauterine System(Ⅲ)

Product Name
左炔诺孕酮宫内节育系统(Ⅲ)
Approval Number
H20180096
Approval Date
Dec 25, 2018
NMPA

Disodium Clodronate Capsules

Product Name
固令
Approval Number
J20160032
Approval Date
Mar 25, 2016
NMPA

Disodium Clodronate Capsules

Product Name
固令
Approval Number
国药准字J20160032
Approval Date
Mar 25, 2016
NMPA

Disodium Clodronate Capsules

Product Name
固令
Approval Number
H20150668
Approval Date
Dec 2, 2015
NMPA

Disodium Clodronate Capsules

Product Name
固令
Approval Number
H20150632
Approval Date
Dec 2, 2015
NMPA

Disodium Clodronate Injection

Product Name
氯膦酸二钠注射液
Approval Number
国药准字J20140109
Approval Date
Sep 5, 2014
NMPA

Disodium Clodronate Injection

Product Name
氯膦酸二钠注射液
Approval Number
H20140395
Approval Date
Jun 4, 2014
NMPA

Disodium Clodronate Injection

Product Name
氯膦酸二钠注射液
Approval Number
H20140396
Approval Date
Jun 4, 2014
NMPA

Levonorgestrel Intrauterine System

Product Name
左炔诺孕酮宫内释放系统
Approval Number
H20140370
Approval Date
May 26, 2014
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.